Cancer Incidence and Mortality among Non-Hispanic Individuals, Queens County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 9,450.2 440.6 436.5-444.7 4,576.0 466.9 460.8-473.2 4,874.2 426.6 421.0-432.2 2,702.8 119.9 117.8-122.0 1,344.8 140.0 136.6-143.5 1,358.0 106.3 103.7-109.0
Oral cavity and pharynx 211.2 9.9 9.3-10.5 129.4 13.2 12.2-14.3 81.8 7.2 6.5-8.0 46.8 2.1 1.8-2.4 30.6 3.1 2.6-3.7 16.2 1.3 1.0-1.6
Esophagus 81.6 3.6 3.2-3.9 60.0 5.9 5.3-6.7 21.6 1.6 1.3-2.0 57.4 2.5 2.2-2.8 43.6 4.4 3.8-5.1 13.8 1.0 0.8-1.3
Stomach 255.4 11.8 11.1-12.5 149.6 15.6 14.5-16.8 105.8 8.8 8.0-9.6 100.4 4.5 4.1-4.9 62.8 6.6 5.9-7.4 37.6 2.9 2.5-3.4
Colorectal 826.8 38.3 37.1-39.6 429.0 44.4 42.5-46.4 397.8 33.3 31.8-34.9 267.2 11.8 11.2-12.5 126.8 13.2 12.2-14.3 140.4 10.8 10.0-11.6
Colon excluding rectum 587.2 27.0 26.1-28.1 294.6 30.6 29.0-32.2 292.6 24.1 22.8-25.4 222.2 9.8 9.3-10.5 102.0 10.7 9.8-11.7 120.2 9.2 8.5-10.0
Rectum & rectosigmoid 239.6 11.3 10.6-12.0 134.4 13.8 12.8-14.9 105.2 9.2 8.4-10.1 45.0 2.0 1.7-2.3 24.8 2.5 2.1-3.0 20.2 1.6 1.3-1.9
Liver / intrahepatic bile duct 217.2 9.8 9.2-10.4 156.0 15.4 14.3-16.6 61.2 5.0 4.5-5.7 138.4 6.2 5.7-6.7 94.2 9.5 8.6-10.4 44.2 3.5 3.1-4.1
Pancreas 304.4 13.4 12.7-14.1 140.8 14.3 13.3-15.5 163.6 12.5 11.7-13.5 224.4 9.7 9.2-10.3 104.8 10.5 9.6-11.5 119.6 8.9 8.2-9.7
Larynx 51.2 2.2 2.0-2.5 43.2 4.3 3.7-4.9 8.0 0.6 0.4-0.9 14.6 0.6 0.5-0.8 11.8 1.2 0.9-1.6 2.8 0.2 0.1-0.4
Lung and bronchus 1,062.0 47.1 45.9-48.5 547.4 55.8 53.6-57.9 514.6 40.8 39.2-42.4 509.8 22.3 21.5-23.2 281.0 29.0 27.5-30.6 228.8 17.4 16.4-18.5
Melanoma of the skin 184.2 8.6 8.0-9.2 103.2 10.9 9.9-11.9 81.0 7.0 6.3-7.8 22.4 1.1 0.9-1.3 13.4 1.4 1.1-1.8 9.0 0.8 0.5-1.0
Female breast             1,489.0 135.3 132.1-138.5             218.6 18.0 16.9-19.1
Cervix uteri             91.2 9.0 8.1-9.9             23.8 2.1 1.7-2.5
Corpus uterus and NOS             373.6 31.5 30.1-33.1             84.8 6.7 6.0-7.4
Ovary             131.8 12.2 11.3-13.3             71.2 5.8 5.2-6.4
Prostate       1,232.0 117.3 114.3-120.3             150.2 15.9 14.8-17.1      
Testis       36.0 4.5 3.9-5.3             1.0 0.1 0.0-0.3      
Urinary bladder (incl. in situ) 386.2 17.1 16.3-17.9 291.4 30.2 28.7-31.9 94.8 7.3 6.7-8.1 69.4 3.0 2.7-3.3 49.4 5.2 4.6-6.0 20.0 1.5 1.2-1.8
Kidney and renal pelvis 316.6 14.9 14.2-15.7 204.4 21.3 20.0-22.7 112.2 9.6 8.8-10.5 50.6 2.3 2.0-2.6 32.8 3.4 2.9-4.0 17.8 1.4 1.1-1.8
Brain and other central nervous system 102.6 5.4 4.9-5.9 56.0 6.3 5.5-7.1 46.6 4.6 4.0-5.3 61.8 3.0 2.6-3.4 32.0 3.5 3.0-4.1 29.8 2.5 2.1-3.0
Thyroid 373.0 20.9 19.9-21.9 93.0 10.7 9.7-11.7 280.0 30.4 28.8-32.1 11.8 0.5 0.4-0.7 5.4 0.6 0.4-0.8 6.4 0.5 0.3-0.7
Hodgkin lymphoma 45.4 2.7 2.3-3.1 25.6 3.1 2.6-3.7 19.8 2.3 1.8-2.8 3.6 0.2 0.1-0.3 2.2 0.2 0.1-0.4 1.4 0.1 0.0-0.3
Non-Hodgkin lymphomas 389.4 18.3 17.5-19.2 210.6 22.2 20.9-23.7 178.8 15.2 14.2-16.3 89.4 3.9 3.6-4.3 51.8 5.5 4.8-6.2 37.6 2.7 2.4-3.2
Myeloma 174.0 7.8 7.3-8.3 88.8 8.9 8.1-9.8 85.2 6.9 6.2-7.6 59.4 2.5 2.3-2.9 29.8 3.0 2.6-3.6 29.6 2.2 1.9-2.6
Leukemias 277.0 13.5 12.8-14.3 158.2 17.4 16.1-18.7 118.8 10.5 9.7-11.5 105.8 4.8 4.3-5.2 60.8 6.5 5.8-7.3 45.0 3.5 3.1-4.1

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.